
We're building the future of AI and biology together.
SynBioBeta 2027, May 3-6, San Jose.

Christopher Bettinger
Novo Nordisk Foundation
VP of Biotechnology

Emily Leproust
Twist Bioscience
CEO

Eric Topol
Scripps Research
Founder and Director

George Church
Harvard Medical School
Professor

Jenny Rooke
Genoa Ventures
Managing Director

Michael Koeris
DARPA
Director, BTO

Alex Rives
CZI Biohub
Head of Science

Ian Watson
Department of Defense
Deputy Assistant Secretary of Defense

Joe Hedley
NunaBio
CEO

Jose Carlos Garcia-Garcia
Procter & Gamble
Head of Corporate Biotech.

Lotte Bjerre Knudsen
Aarhus University
Honorary Professor in Translational Medicine

Omri Amirav-Drory
NFX
General Partner

Aliza Apple
Eli Lilly
Vice President of Catalyze360 AI/ML

Jason Gammack
Ansa Biotechnologies
CEO

Karen Akinsanya
Schrodinger
President, R&D – Therapeutics
Meet the Sponsors & Exhibitors

NunaBio

Anocca AB

Origenity

Twist Bioscience

Cradle

Matterworks

Ansa Biotechnologies

Centivax

Arzeda

Procter & Gamble

Pumpkinseed
Bunker Bio

Federov

Genoa Ventures

Dyno Therapeutics

EverGlade Consulting

Genyro

Aminoverse

GenScript

Acrisure

Lab Thread

Gator Bio

Bio Base Europe Pilot Plant

Joint BioEnergy Institute (JBEI)

Bold View Capital

Chromatin Bioscience

DoriNano Inc

Evonik

GRIDX

Hamilton Company

New England Biolabs

Omega Bio-Tek

Solaris Biotech by Donaldson

Genomic Intelligence

Ingenza

Substrate Bio

Agentic Bio

IKA Works

Andgel Industrial (Shanghai) Co., Ltd.

Xellsion.AI

Flock Bio

Wexford Connect Labs

Sunthetics AI

Talaria Biosciences

Miibio

Angstrom Innovation

Frontiers

The Bioforge

Twig

3dr

Bay Area Cancer Connections

Korea Institute Of Science And Technology
Why People Keep Coming Back

”
SynBioBeta is a who’s who of AI and biology. This is where the future is being built, so don't miss it.
Eric Schmidt
Former CEO


”
Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal.
Surge Biswas
Founder


”
I met Algen at SynBioBeta and later invested in the company. It's exactly the kind of connection that makes the community so valuable.
Bill Tai
Co-founder


”
For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta.
Celestine Schnugg
Founder

AI-powered therapeutics, precision medicine, and longevity. The founders, the pharma leaders, and the investors.
View Theme

Synthesis, editing, multi-omics, and automation — the stack from base pair to bioreactor. The toolmakers, the platform builders, and the labs that run on them.
View Theme

Foods, materials, chemicals, and ingredients made by biology — and priced to win. The founders, the manufacturers, and the buyers scaling them.
View Theme

Where bio capital actually moves — deals, valuations, and non-dilutive funding. The VCs, the philanthropists, and the founders raising.
View Theme

Foundation models, virtual cells, AI-designed molecules, and the companies putting them to work.
View Theme

Synthesis screening, countermeasure capacity, and governance racing the tools. The scientists, the agencies, and the policymakers holding the line.
View Theme

Prices Increase After Midnight Sunday, January 31. Lock In Your Rate Now.
All passes are fully refundable.
Students: Join our Next-Generation Leaders Program
Secure Your Spot in the Exhibit Hall


